Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The observation that the insulinotropic actions of GLP-1 are reduced in type 2 diabetes mellitus (T2DM) led to the development of incretin-based therapies GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of hyperglycaemia in these patients
AOD 9604 is a modified fragment of human growth hormone (HGH) , specifically, the lipolytic (fat-burning) region of the hormone
Who Is Eligible
When you diet, your fat cells shrink
US$ 22.54
US$ 23.89
US$ 28.66
US$ 22.44
US$ 21.15
